The latest closing stock price for Vivos Therapeutics as of January 31, 2025 is 3.97.
An investor who bought $1,000 worth of Vivos Therapeutics stock at the IPO in 2020 would have $-558 today, roughly -1 times their original investment - a -18.48% compound annual growth rate over 4 years.
The all-time high Vivos Therapeutics stock closing price was 41.00 on November 29, 2023.
The Vivos Therapeutics 52-week high stock price is 6.45, which is 62.5% above the current share price.
The Vivos Therapeutics 52-week low stock price is 1.91, which is 51.9% below the current share price.
The average Vivos Therapeutics stock price for the last 52 weeks is 3.28.
An investor who bought $1,000 worth of Vivos Therapeutics stock at the IPO in 2020 would have $-558 today, roughly -1 times their original investment - a -18.48% compound annual growth rate over 4 years.
The all-time high Vivos Therapeutics stock closing price was 41.00 on November 29, 2023.
The Vivos Therapeutics 52-week high stock price is 6.45, which is 62.5% above the current share price.
The Vivos Therapeutics 52-week low stock price is 1.91, which is 51.9% below the current share price.
The average Vivos Therapeutics stock price for the last 52 weeks is 3.28.